Comienzos
keyboard_arrow_right
keyboard_arrow_right
Alba Therapeutics announces next clinical trial of lead compound.
Nutrition

Alba Therapeutics announces next clinical trial of lead compound.

Related StoriesScientists discover small molecule that may block development of BRCA-deficient malignancy cellsBreastfeeding may not drive back allergiesNew research displays siblings of kids with food allergy symptoms have sensitivity, but not true Arterburn allergyLinda, PhD, formerly Vice President, Preclinical Development and System Management, has been promoted to Vice President of Advancement at Alba. Ahead of signing up for Alba in March 2007, Dr. Arterburn was Executive Director of Discovery Analysis at Martek Biosciences. In this capability, she initiated an swelling research system and was lead inventor on two patents regarding novel anti-inflammatory lipids.We began as a cooperative 60 years back, so that we’re actually capitalized by the people and they create cooperative governance. We’ve 23 clinics. We have doctors. We have nurses. Then we also do the financing of health care, so we have the insurance mechanisms aswell. That whole procedure is governed by customers, and that’s the part that’s really unusual about Group Wellness . This article is republished with kind permission from our close friends at The Kaiser Family Foundation.